Top Page
Finexia Financial Group Ltd
(Sydney:FNX)
Finexia Financial Group Ltd (FNX) vs. iShares MSCI Australia ETF (EWA)
Finexia Financial Group Ltd Business Overview & Revenue Model
Finexia Financial Group Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.67M | 10.67M | 16.17M | 14.22M | 10.23M | 2.07M |
| Gross Profit | 10.67M | 10.67M | 7.60M | 13.62M | 7.16M | 4.55M |
| EBITDA | 18.63M | 9.93M | 8.99M | 9.62M | 6.26M | 1.30M |
| Net Income | -3.13M | -3.13M | 70.49K | 3.21M | 3.29M | 1.27M |
Balance Sheet | ||||||
| Total Assets | 150.73M | 150.73M | 112.84M | 77.82M | 53.08M | 24.16M |
| Cash, Cash Equivalents and Short-Term Investments | 8.64M | 8.64M | 46.83M | 46.16M | 13.60M | 4.49M |
| Total Debt | 130.76M | 130.76M | 92.67M | 58.14M | 41.53M | 17.26M |
| Total Liabilities | 134.96M | 134.96M | 96.64M | 61.10M | 44.24M | 19.00M |
| Stockholders Equity | 15.76M | 15.76M | 16.20M | 16.72M | 8.84M | 5.16M |
Cash Flow | ||||||
| Free Cash Flow | -1.82M | -1.82M | 2.28M | 1.35M | 4.62M | 301.77K |
| Operating Cash Flow | -1.81M | -1.81M | 2.71M | 1.38M | 4.62M | 350.20K |
| Investing Cash Flow | -15.14K | -15.14K | -435.22K | -946.40K | -3.49M | 953.95K |
| Financing Cash Flow | 3.63M | 3.63M | -1.19M | 2.59M | 129.15K | -213.32K |
Finexia Financial Group Ltd Technical Analysis
Finexia Financial Group Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | AU$489.39M | 24.55 | 12.36% | 2.61% | -26.30% | 40.12% | |
59 Neutral | AU$136.71M | 5.64 | 9.31% | ― | -5.73% | -36.36% | |
57 Neutral | AU$430.58M | 31.80 | 12.27% | 2.62% | 24.56% | 59.32% | |
53 Neutral | €99.07M | -151.61 | -0.15% | ― | 5.03% | 52.31% | |
46 Neutral | AU$8.10M | ― | -34.88% | ― | 43.00% | -6078.57% | |
42 Neutral | AU$3.69M | -0.77 | -444.41% | ― | -37.25% | 27.45% |
Finexia Financial Group Ltd Corporate Events
Finexia Financial Group Limited, listed on the Australian Securities Exchange under the ticker FNX, has announced that the suspension of its trading securities will be lifted. This follows the company’s release of an announcement addressing recent media speculation, allowing for the reinstatement of its securities to quotation.
Finexia Financial Group Limited has addressed recent media speculation regarding a potential reverse listing transaction with Salter Brothers, clarifying that discussions were preliminary and have now ceased. The company confirms it is not engaged in any negotiations for such a transaction and seeks the reinstatement of its securities on the ASX, maintaining its commitment to continuous disclosure obligations.
Finexia Financial Group Limited has announced its Annual General Meeting (AGM) scheduled for November 26, 2025, at Aurora Place in Sydney. The company emphasizes the importance of shareholder participation and provides multiple methods for submitting proxy votes. Shareholders are encouraged to monitor the company’s website and ASX announcements for any updates regarding the meeting.
Finexia Financial Group Ltd has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, confirming that the company has followed these guidelines throughout the reporting period. This disclosure is part of the company’s commitment to transparency and accountability, which is crucial for maintaining stakeholder trust and ensuring robust governance practices.
Finexia Financial Group Ltd has released its annual report for the year ending June 30, 2025. The report includes detailed financial statements and disclosures, reflecting the company’s financial performance and position. This release is crucial for stakeholders to assess Finexia’s operational health and strategic direction in the competitive financial services market.
Finexia Financial Group Limited has announced an additional impairment adjustment of $2.2 million to its investment in The Stay Company Income Fund, bringing the total impairment for FY25 to over $6.2 million. This adjustment increases the company’s reported loss before tax for the fiscal year to $6.8 million, highlighting significant financial challenges. Additionally, the company has written down a receivable related to Dragonfly Biosciences by $543,039 due to recovery doubts, impacting the financial position as reported in the 2025 Annual Report.
Finexia Financial Group Limited announced a restatement of its FY24 accounts due to an under-accrual of interest and operating expenses, which has been corrected in the financial statements. The company also revised the valuation of its investment in the Stay Company Income Fund, resulting in a write-down of $4,013,463, reflecting a fair and reasonable assessment of asset value. These actions underscore Finexia’s commitment to transparency and governance.
Finexia Financial Group Ltd reported a significant increase in revenue from continuing operations, reaching $23.8 million, a 59% rise compared to the previous year. Despite this growth, the company experienced a net loss after tax of $3.13 million for the year ended 30 June 2025, which is a substantial increase from the previous year’s loss. This financial performance reflects challenges in managing expenses and interest accruals, impacting the company’s net tangible assets per security, which decreased to 19.82 cents.
Finexia Financial Group Limited, listed on the Australian Securities Exchange (ASX) under the ticker FNX, has had its securities suspended from quotation. This suspension is due to pending announcements related to media speculation and a potential material acquisition, which could significantly impact the company’s operations and market positioning.
Finexia Financial Group Limited has requested a trading halt on its securities pending an announcement related to speculation about a potential transaction, as reported by the Australian Financial Review. The halt is expected to last until the earlier of the release of the announcement or the resumption of normal trading on 29 August 2025, indicating a significant development that could impact the company’s market position and stakeholder interests.